Medication info
Tracom Tablet (Tramadol Hydrochloride, Acetaminophen)

Tracom Tablet (Tramadol Hydrochloride, Acetaminophen)

Prescription medicationTabletOral
Ingredient · strength
Tramadol Hydrochloride›37.5mg / 1 tabletAcetaminophen›325mg / 1 tablet
Manufacturer / importer
Yian Pharmaceutical Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200804958 · Notified 2008.04.30 · Insurance code 658601980

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be spaced at least 6 hours apart, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible period. Do not use this medicine for longer than necessary. If long-term use is required due to the nature and severity of the disease, perform regular monitoring to determine whether treatment with this medicine should continue. Elderly patients Use the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance below 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to administer another dose of this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: An initial dose of 2 tablets is recommended. Thereafter, doses should be spaced at least 6 hours apart, and no more than 8 tablets should be taken in 1 day.

Ingredients

Manufacturer
Yian Pharmaceutical Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • chronic pain
View approved original text

This medication is used to relieve moderate to severe acute and chronic pain.

How to take

Adult dose

Adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be spaced at least 6 hours apart, and no more than 8 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible period. Do not use this medicine for longer than necessary. If long-term use is required due to the nature and severity of the disease, perform regular monitoring to determine whether treatment with this medicine should continue. Elderly patients Use the usual adult dose. However, because the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance below 10ml/min). Because tramadol is removed very slowly by hemodialysis and filtration, there is no need to administer another dose of this medicine after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: An initial dose of 2 tablets is recommended. Thereafter, doses should be spaced at least 6 hours apart, and no more than 8 tablets should be taken in 1 day.

Precautions

This medication can put strain on the liver; therefore, individuals who regularly consume more than three alcoholic drinks a day should consult with a doctor or pharmacist before taking it. Due to the acetaminophen component, serious skin rashes or allergic reactions may rarely occur. If a rash or hypersensitivity symptoms appear, discontinue use immediately and seek medical attention. The main ingredient, tramadol, can increase the risk of seizures if the recommended dosage is exceeded, and taking it with certain antidepressants or narcotics can further increase this risk. For patients with severe respiratory conditions, there is a risk of respiratory depression, so such patients should be monitored carefully when this medication is administered in a facility equipped for this purpose. Taking this medication with alcohol or central nervous system depressants can cause severe drowsiness, respiratory depression, or coma, so co-administration should be avoided or should only be done at the minimal dose for a short period when necessary. Patients with increased intracranial pressure or head injuries may experience worsened symptoms while taking this medication, which requires caution. This medication can cause dependence, so if it is used for a long time, the duration and dosage should be adjusted to consider the risk of dependence and abuse. Patients with impaired liver function should consult a doctor before taking this medication, and caution should be taken to avoid concurrent use with other acetaminophen products. For patients with specific genotypes, metabolism of this medication may be accelerated, increasing the risk of respiratory depression, necessitating the use of alternative medications or dose adjustments. This medication should not be administered to children under 12 years old or adolescents under 18 years old who have undergone tonsillectomy and adenoidectomy. Patients with sleep apnea or at risk of hypoxia should be continuously monitored for symptom exacerbation during treatment with this medication. Dose adjustments or discontinuation should be considered as needed. This medication can rarely cause hyponatremia, so patients, especially elderly or at-risk individuals, should periodically check their serum sodium levels. This medication should not be administered to individuals with certain allergies, central nervous system drug intoxication, severe respiratory depression, head trauma, or those taking MAO inhibitors. Drowsiness, dizziness, nausea, constipation, and other side effects may occur during use, so caution is needed when driving or operating machinery. In case of overdose, serious respiratory depression, seizures, liver damage, etc., may occur, so do not exceed the prescribed dose, and if overdose is suspected, seek medical attention immediately. This medication should be kept out of reach of children in a safe place, and precautions should be taken to prevent misuse or abuse by blocking access to others.

Side effects

Liver damage, acute generalized eruptive pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reaction, respiratory depression, deep sedation, coma, fatal respiratory depression, hyponatremia, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, irritability, emotional instability, euphoria, decreased libido, sleep disorders, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory loss, tremors, paresthesia, attention deficit, fainting, memory impairment, psychomotor hyperactivity, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, miosis, vertigo, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweat, urination disorders, erectile dysfunction, asthenia, chest pain, emotional instability, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylaxis reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, unstable emotions, delirium, suicidal thoughts, muscular hypertonia, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbance, prolonged prothrombin time, fixed rash, asthenia, fever, edema, rigidity, fainting, congestive heart failure, dizziness, confusion, exacerbation of migraine, involuntary muscle contractions, dyspnea, asthma, exercise-induced dyspnea, cough, bronchitis, urine retention, frequent urination, abnormal renal function values, oliguria, increased sweating, urticaria, dysphagia, tongue swelling, increased salivation, progression of colorectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, loss of appetite, anxiety, depression, irritability, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, decreased platelets, palpitations, arrhythmia, exacerbation of hypertension, aortic stenosis, gastrointestinal bleeding, elevated cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, nausea, dizziness, paralytic ileus, cholecystitis, abnormal renal function values, increased salivation, gastrointestinal bleeding, vomiting, dyspepsia, confusion, multiple organ failure, intentional overdose, belching, chest discomfort, anxiety, sweating, rigidity, pain, tremors, diarrhea, upper respiratory syndrome, excessive yawning, agitation, hyperactivity, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system reactions, urticaria, rash, bronchospasm, toxic skin necrosis, anaphylactic reaction, convulsions, serotonin syndrome, respiratory depression, hypotension, deep sedation, coma, death, QT interval prolongation, somnolence, coma, cardiac arrest, death, abdominal discomfort, nausea, lethargy, pallor, hyperhidrosis, symptoms of acute or chronic adrenal insufficiency, opioid-induced hyperalgesia, withdrawal symptoms, respiratory arrest

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from penetrating. Additionally, avoid storing it in excessively hot or cold places; it is best to store it at room temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.